Format

Send to

Choose Destination
Korean J Radiol. 2019 Apr;20(4):589-598. doi: 10.3348/kjr.2018.0306.

Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer.

Lee DH1,2, Kim SH1,3, Lee SM4, Han JK1,2,5.

Author information

1
Department of Radiology, Seoul National University Hospital, Seoul, Korea.
2
Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
3
Department of Radiology, Seoul National University College of Medicine, Seoul, Korea. shkim7071@gmail.com.
4
Department of Radiology, Hallym University Sacred Heart Hospital, Seoul, Korea.
5
Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea.

Abstract

OBJECTIVE:

To evaluate whether data acquired from perfusion computed tomography (PCT) parameters can aid in the prediction of treatment outcome after palliative chemotherapy in patients with unresectable advanced gastric cancer (AGC).

MATERIALS AND METHODS:

Twenty-one patients with unresectable AGCs, who underwent both PCT and palliative chemotherapy, were prospectively included. Treatment response was assessed according to Response Evaluation Criteria in Solid Tumors version 1.1 (i.e., patients who achieved complete or partial response were classified as responders). The relationship between tumor response and PCT parameters was evaluated using the Mann-Whitney test and receiver operating characteristic analysis. One-year survival was estimated using the Kaplan-Meier method.

RESULTS:

After chemotherapy, six patients exhibited partial response and were allocated to the responder group while the remaining 15 patients were allocated to the non-responder group. Permeability surface (PS) value was shown to be significantly different between the responder and non-responder groups (51.0 mL/100 g/min vs. 23.4 mL/100 g/min, respectively; p = 0.002), whereas other PCT parameters did not demonstrate a significant difference. The area under the curve for prediction in responders was 0.911 (p = 0.004) for PS value, with a sensitivity of 100% (6/6) and specificity of 80% (12/15) at a cut-off value of 29.7 mL/100 g/min. One-year survival in nine patients with PS value > 29.7 mL/100 g/min was 66.7%, which was significantly higher than that in the 12 patients (33.3%) with PS value ≤ 29.7 mL/100 g/min (p = 0.019).

CONCLUSION:

Perfusion parameter data acquired from PCT demonstrated predictive value for treatment outcome after palliative chemotherapy, reflected by the significantly higher PS value in the responder group compared with the non-responder group.

KEYWORDS:

Functional imaging; Permeability; Reproducibility; Stomach; Survival

Supplemental Content

Full text links

Icon for The Korean Radiological Society Icon for PubMed Central
Loading ...
Support Center